Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
142,000
0.00 (0.00%)
At close: Mar 9, 2026
HNX:PMC Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 40,564 | 60,084 | 13,252 | 37,454 | 29,430 | Upgrade
|
| Short-Term Investments | 500 | 141,000 | 249,000 | 256,100 | 242,131 | Upgrade
|
| Cash & Short-Term Investments | 41,064 | 201,084 | 262,252 | 293,554 | 271,560 | Upgrade
|
| Cash Growth | -79.58% | -23.32% | -10.66% | 8.10% | 19.88% | Upgrade
|
| Accounts Receivable | 33,666 | 41,222 | 39,310 | 35,254 | 39,175 | Upgrade
|
| Other Receivables | 781.3 | 3,042 | 3,605 | 3,233 | 2,159 | Upgrade
|
| Receivables | 34,448 | 44,264 | 42,915 | 38,487 | 41,335 | Upgrade
|
| Inventory | 107,458 | 71,119 | 67,244 | 104,546 | 71,379 | Upgrade
|
| Prepaid Expenses | 3,564 | 435.06 | 453.29 | 282.38 | 915.04 | Upgrade
|
| Other Current Assets | 33,043 | 18,533 | 6,207 | 4,273 | 3,853 | Upgrade
|
| Total Current Assets | 219,576 | 335,436 | 379,071 | 441,141 | 389,042 | Upgrade
|
| Property, Plant & Equipment | 93,635 | 32,127 | 39,704 | 45,890 | 53,900 | Upgrade
|
| Other Intangible Assets | 1,998 | 2,214 | 2,443 | 2,731 | 2,991 | Upgrade
|
| Other Long-Term Assets | 30,216 | 6,062 | 5,157 | 4,362 | 5,560 | Upgrade
|
| Total Assets | 345,424 | 375,839 | 426,375 | 494,124 | 451,494 | Upgrade
|
| Accounts Payable | 26,085 | 16,250 | 12,730 | 15,668 | 8,378 | Upgrade
|
| Accrued Expenses | 45,925 | 44,572 | 46,302 | 36,141 | 38,986 | Upgrade
|
| Short-Term Debt | 181.01 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 7,560 | 6,580 | 7,821 | 7,364 | 7,203 | Upgrade
|
| Current Unearned Revenue | 1,941 | 1,457 | 1,002 | 669.46 | 804.02 | Upgrade
|
| Other Current Liabilities | 22,877 | 17,369 | 15,322 | 6,500 | 7,246 | Upgrade
|
| Total Current Liabilities | 104,569 | 86,227 | 83,178 | 66,342 | 62,617 | Upgrade
|
| Total Liabilities | 104,569 | 86,227 | 83,178 | 66,342 | 62,617 | Upgrade
|
| Common Stock | 93,326 | 93,326 | 93,326 | 93,326 | 93,326 | Upgrade
|
| Additional Paid-In Capital | 972.97 | 972.97 | 972.97 | 972.97 | 972.97 | Upgrade
|
| Retained Earnings | 146,557 | 195,313 | 248,898 | 333,483 | 294,578 | Upgrade
|
| Total Common Equity | 240,855 | 289,612 | 343,197 | 427,782 | 388,877 | Upgrade
|
| Shareholders' Equity | 240,855 | 289,612 | 343,197 | 427,782 | 388,877 | Upgrade
|
| Total Liabilities & Equity | 345,424 | 375,839 | 426,375 | 494,124 | 451,494 | Upgrade
|
| Total Debt | 181.01 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | 40,883 | 201,084 | 262,252 | 293,554 | 271,560 | Upgrade
|
| Net Cash Growth | -79.67% | -23.32% | -10.66% | 8.10% | 19.88% | Upgrade
|
| Net Cash Per Share | 4380.69 | 21546.50 | 28100.75 | 31454.72 | 29098.14 | Upgrade
|
| Filing Date Shares Outstanding | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | Upgrade
|
| Total Common Shares Outstanding | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | Upgrade
|
| Working Capital | 115,007 | 249,208 | 295,893 | 374,799 | 326,425 | Upgrade
|
| Book Value Per Share | 25808.03 | 31032.37 | 36774.09 | 45837.52 | 41668.77 | Upgrade
|
| Tangible Book Value | 238,858 | 287,397 | 340,754 | 425,052 | 385,886 | Upgrade
|
| Tangible Book Value Per Share | 25593.97 | 30795.08 | 36512.36 | 45544.94 | 41348.27 | Upgrade
|
| Buildings | 33,322 | 32,966 | 32,966 | 32,966 | 32,966 | Upgrade
|
| Machinery | 255,859 | 190,875 | 187,316 | 182,470 | 181,032 | Upgrade
|
| Construction In Progress | 2,418 | 68.69 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.